000 01205 a2200385 4500
005 20250513112808.0
264 0 _c19970324
008 199703s 0 0 eng d
022 _a0002-9173
024 7 _a10.1093/ajcp/107.3.337
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoteat, H T
245 0 0 _aThe utility of patient age in evaluating prostate cancer.
_h[electronic resource]
260 _bAmerican journal of clinical pathology
_cMar 1997
300 _a337-44 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAge Distribution
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aReference Values
650 0 4 _aSensitivity and Specificity
700 1 _aHo, G T
700 1 _aLee, M L
700 1 _aWelch, W R
700 1 _aLoughlin, K R
700 1 _aSacks, D B
773 0 _tAmerican journal of clinical pathology
_gvol. 107
_gno. 3
_gp. 337-44
856 4 0 _uhttps://doi.org/10.1093/ajcp/107.3.337
_zAvailable from publisher's website
999 _c9040545
_d9040545